상품상세정보

의학서적전문 "성보의학서적"의 신간의학도서입니다.

This expert volume in the Diagnostic Pathology series is an excellent point-of-care resource for practitioners at all levels of experience and training. Providing a clear understanding of molecular pathology as it relates to the transformation and pathogenesis of cancer in an era of personalized medicine, it incorporates the most recent scientific and technical knowledge in the field to provide a comprehensive overview of all key issues relevant to today’s practice. Richly illustrated and easy to use, the third edition of Diagnostic Pathology: Molecular Oncology is a visually stunning, one-stop resource for every practicing pathologist, hematopathologist, molecular pathologist, oncologist, or pathologist in training as an ideal day-to-day reference or as a reliable learning resource.
Provides up-to-date, comprehensive coverage of relevant molecular tests and their clinical applications, along with organ-based chapters on the molecular genetic data relevant to individual disease entities
Contains new chapters and substantial revisions to existing content that include updates from the 2022 International Consensus Classification and the 5th edition WHO Classification of Hematolymphoid Tumors
Provides expert guidance on selecting the right test(s) at the right time, as well as comparisons of molecular testing methods ( FISH vs. cytogenetics, for example)
Includes current information for new actionable mutations and targeted therapies
Covers ultrasensitive molecular techniques for minimal residual disease detection and disease monitoring  
Discusses circulating cell-free DNA analysis for detection of resistance-associated mutations and disease monitoring, and provides usage details
Features an image-rich layout with more than 2,300 print and online images— high-resolution H&E stains, immunostains, FISH images, gross pathology and clinical photographs, detailed full-color medical illustrations, and informative diagrams, charts, and schematics
Employs consistently templated chapters, bulleted content, key facts, a variety of tables, annotated images, pertinent references, and an extensive index for quick, expert reference at the point of care
Includes an eBook version that enables you to access all text, figures, and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud
Molecular oncology is a rapidly evolving field with tremendous amounts of information that is new since the 2e published in March 2019. There is new molecular genetic data linked to either new targeted therapies or that serves as diagnostic or prognostic indicators. The 3e will include 8-10 new chapters and substantial updates and rewrites to existing contents to make sure ongoing edits and revisions to the upcoming WHO Classification of Hematopoietic Tumors are included in the 3e. The authors provide guidance on selecting the right test(s) at the right time for the right patient and comparisons of molecular testing methods (i.e., FSH testing vs. cytogenetics) are included. The market lacks a definitive source of all the recent changes, and DP3 Molecular Oncology will provide a comprehensive information source.

-도서목차-

SECTION 1: INTRODUCTION
4 Structure of Chromosomes and Nucleic Acids

Jeremy C. Wallentine, MD

8 DNA Replication, Transcription, and Translation

Jeremy C. Wallentine, MD

12 Gene Mutations

Jeremy C. Wallentine, MD

SECTION 2: COMMON TECHNIQUES FOR ANALYSIS OF ALTERATIONS IN CHROMOSOMES AND DNA

18 Cytogenetics and FISH

Mohammad A. Vasef, MD and David R. Czuchlewski, MD

22 Chromosomal Microarray

Sibel Kantarci, PhD, Durga Cherukuri, PhD, and

Mohammad A. Vasef, MD

26 Amplification Methods

Devon Chabot-Richards, MD

30 DNA High-Resolution Melting Curve Analysis

Amer Mahmoud, MD, FCAP

32 Sequencing Technologies

Eric Y. Loo, MD and Mohammad A. Vasef, MD

36 High-Throughput Methods in Molecular Pathology

Rama Gullapalli, MD, PhD

38 DNA Methylation Analysis

Devon Chabot-Richards, MD

SECTION 3: MOLECULAR GENETIC TESTS IN HEMATOPOIETIC TUMORS

42 BCR::ABL1 Fusion Gene

Eric Y. Loo, MD and Mohammad A. Vasef, MD

46 PML::RARA Fusion Gene

Devon Chabot-Richards, MD

48 Reverse Transcription PCR for Other Myeloid

Leukemia Transcripts

Kristin Hunt Karner, MD

50 FLT3, NPM1, and CEBPA Mutations

Devon Chabot-Richards, MD

54 JAK2 Mutations and Rearrangements

Mohammad A. Vasef, MD

56 MPL Mutations

Eric Y. Loo, MD and David R. Czuchlewski, MD

58 Calreticulin (CALR) Mutations

Eric Y. Loo, MD and Mohammad A. Vasef, MD

60 CSF3R Mutations

Amer Mahmoud, MD, FCAP

62 SETBP1 Mutations

Amer Mahmoud, MD, FCAP

64 KIT Mutations

Eric Y. Loo, MD and Mohammad A. Vasef, MD

68 IDH1 and IDH2 Mutations

Eric Y. Loo, MD and David R. Czuchlewski, MD

70 Other Mutations and Gene Panel Testing in Myeloid Neoplasms

Mohammad A. Vasef, MD and David R. Czuchlewski, MD

72 Immunoglobulin Heavy (IGH) Chain Gene

Rearrangements

Mohammad A. Vasef, MD and Anna P. Matynia, MD

76 T-Cell Receptor Gamma (TRG) and Delta (TRD) Chain

Rearrangements

Mohammad A. Vasef, MD and Anna P. Matynia, MD

80 T-Cell Receptor Beta (TRB) Chain Gene

Rearrangements

Mohammad A. Vasef, MD and Anna P. Matynia, MD

84 Southern Blot Analysis of Antigen Receptor Genes

Mohammad A. Vasef, MD

86 EBV-Associated Human Neoplasms

Mohammad A. Vasef, MD

94 MYD88 Mutation

Giovanni Insuasti-Beltran, MD

96 NOTCH1 Mutation

Giovanni Insuasti-Beltran, MD

98 EZH2 Mutation

Amer Mahmoud, MD, FCAP

SECTION 4: MOLECULAR GENETIC TESTS IN SOLID TUMORS, BONE AND SOFT TISSUE TUMORS, AND CNS TUMORS

104 ALK Gene Rearrangements and Mutations

Guanghua Wang, MD

106 ROS1 Rearrangements

Mohammad A. Vasef, MD and David R. Czuchlewski, MD

108 RET Rearrangements

Eric Y. Loo, MD and David R. Czuchlewski, MD

110 FISH for MET Amplifications

Devon Chabot-Richards, MD

114 FISH for ERBB2 (HER2) Gene Amplifications

Kristin Hunt Karner, MD

116 KRAS Mutations

Guanghua Wang, MD

118 BRAF Mutations

Yongjie Zhou, MD, PhD and Guanghua Wang, MD

120 EGFR Mutations

Guanghua Wang, MD

122 Targeted Hotspot Gene Panel Using Massively Parallel Sequencing (Next-Generation Sequencing)

Mohammad A. Vasef, MD and David R. Czuchlewski, MD

124 Targeted Hotspot Gene Panel Table

Mohammad A. Vasef, MD and David R. Czuchlewski, MD

130 MGMT Promoter Gene Methylation Assay

Devon Chabot-Richards, MD

SECTION 5: MOLECULAR PATHOLOGY OF MYELOID NEOPLASMS

134 Molecular Work-Up of Myeloid Neoplasms

Mohammad A. Vasef, MD and David R. Czuchlewski, MD

MYELOPROLIFERATIVE NEOPLASMS

136 Clonal Hematopoiesis and Pre-Malignant Clonal Cytopenia

Mohammad A. Vasef, MD

140 Chronic Myeloid Leukemia, BCR-ABL1 Positive

Mohammad A. Vasef, MD, Kaaren K. Reichard, MD, and David R. Czuchlewski, MD

148 Chronic Neutrophilic Leukemia

Devon Chabot-Richards, MD and David R. Czuchlewski, MD

152 Polycythemia Vera

Mohammad A. Vasef, MD and M. Carmen Frias Kletecka, MD

156 Primary Myelofibrosis

Devon Chabot-Richards, MD and Kaaren K. Reichard, MD

160 Essential Thrombocythemia

Giovanni Insuasti-Beltran, MD

164 Chronic Eosinophilic Leukemia, NOS

Devon Chabot-Richards, MD and Kaaren K. Reichard, MD

166 Myeloproliferative Neoplasms, Unclassifiable

Devon Chabot-Richards, MD and Kaaren K. Reichard, MD

MASTOCYTOSIS

170 Mastocytosis

Mohammad A. Vasef, MD

MYELOID/LYMPHOID NEOPLASMS WITH EOSINOPHILIA AND GENE REARRANGEMENT

178 Myeloid/Lymphoid Neoplasms With Eosinophilia and Gene Rearrangement

Devon Chabot-Richards, MD and David R. Czuchlewski, MD

MYELODYSPLASTIC SYNDROME (MDS)

182 Overview and Classification of Myelodysplastic Syndrome

Devon Chabot-Richards, MD, David R. Czuchlewski, MD, and Carla S. Wilson, MD, PhD

186 Myelodysplastic Syndromes With Single-Lineage Dysplasia

Kristin Hunt Karner, MD

190 Myelodysplastic Syndrome With Ring Sideroblasts

Mohammad A. Vasef, MD and Carla S. Wilson, MD, PhD

194 Myelodysplastic Syndrome With Multilineage Dysplasia

Kristin Hunt Karner, MD

198 Myelodysplastic Syndrome With Isolated del(5q)

Giovanni Insuasti-Beltran, MD

202 Myelodysplastic Syndrome, Unclassifiable

Kristin Hunt Karner, MD

206 Childhood Myelodysplastic Syndrome and Refractory Cytopenia of Childhood

Devon Chabot-Richards, MD and Carla S. Wilson, MD, PhD

MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASMS

212 Overview of Myelodysplastic/Myeloproliferative Neoplasms

Devon Chabot-Richards, MD

214 Chronic Myelomonocytic Leukemia

Kristin Hunt Karner, MD

218 Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative

Devon Chabot-Richards, MD

222 Juvenile Myelomonocytic Leukemia

Devon Chabot-Richards, MD and Qian-Yun Zhang, MD, PhD

224 Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable

Devon Chabot-Richards, MD and Kathryn Foucar, MD

ACUTE MYELOID LEUKEMIA

228 Overview of Acute Myeloid Leukemia

Mohammad A. Vasef, MD and Kaaren K. Reichard, MD

236 Acute Myeloid Leukemia With t(8;21); RUNX1-RUNX1T1

Devon Chabot-Richards, MD, Kaaren K. Reichard, MD, and David R. Czuchlewski, MD

240 Acute Myeloid Leukemia With inv(16) or t(16;16); CBFB-MYH11

Devon Chabot-Richards, MD, Kaaren K. Reichard, MD, and David R. Czuchlewski, MD

244 Acute Promyelocytic Leukemia With t(15;17); PMLRARA

Mohammad A. Vasef, MD

250 Acute Myeloid Leukemia With t(9;11); MLLT3-KMT2A

Devon Chabot-Richards, MD, Kaaren K. Reichard, MD, and David R. Czuchlewski, MD

254 Acute Myeloid Leukemia With t(6:9); DEK-NUP214

Eric Y. Loo, MD and David R. Czuchlewski, MD

256 Acute Myeloid Leukemia With inv(3) or t(3;3); GATA2, MECOM

Eric Y. Loo, MD and David R. Czuchlewski, MD

258 Acute Myeloid Leukemia (Megakaryoblastic) With t(1;22); RBM15-MRTFA

Eric Y. Loo, MD and David R. Czuchlewski, MD

260 Acute Myeloid Leukemia With Myelodysplasia-

Related Changes

Mohammad A. Vasef, MD, David R. Czuchlewski, MD, and Kathryn Foucar, MD

262 Acute Myeloid Leukemia, NOS

Kristin Hunt Karner, MD

268 Therapy-Related Myeloid Neoplasms

Mohammad A. Vasef, MD and Kathryn Foucar, MD

274 Myeloid Sarcoma

Devon Chabot-Richards, MD

278 Myeloid Proliferations Associated With Down Syndrome

Eric Y. Loo, MD and David R. Czuchlewski, MD

BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM

282 Blastic Plasmacytoid Dendritic Cell Neoplasm

Mohammad A. Vasef, MD

SECTION 6: MOLECULAR PATHOLOGY OF LYMPHOID NEOPLASMS

290 Overview of Lymphoid Neoplasms

Nadine Aguilera, MD

294 Molecular Work-Up of Lymphoid Neoplasms

Mohammad A. Vasef, MD and David R. Czuchlewski, MD

DETERMINATION OF CLONALITY IN B-, T-, AND NK-CELL NEOPLASMS

296 Lymphoma-Associated Chromosomal Translocations

Kristin Hunt Karner, MD

PRECURSOR LYMPHOID NEOPLASMS

300 B-Lymphoblastic Leukemia/Lymphoma With Recurrent Genetic Abnormalities

Kristin Hunt Karner, MD

304 B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1- Like (Ph-Like ALL)

Joanna L. Conant, MD and Mohammad A. Vasef, MD

308 T-Lymphoblastic Leukemia/Lymphoma

Mohammad A. Vasef, MD

MATURE B-CELL NEOPLASMS

314 Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia

Devon Chabot-Richards, MD

320 B-Cell Prolymphocytic Leukemia

Aaron Auerbach, MD, MPH

324 Splenic Marginal Zone Lymphoma

Aaron Auerbach, MD, MPH and Roberto N. Miranda, MD

330 Hairy Cell Leukemia

Mohammad A. Vasef, MD

334 Splenic B-Cell Lymphoma/Leukemia, Unclassifiable

Nadine Aguilera, MD

340 Lymphoplasmacytic Lymphoma

Aaron Auerbach, MD, MPH

346 Monoclonal Gammopathy of Undetermined Significance

Nadine Aguilera, MD

350 Plasma Cell Myeloma

Nadine Aguilera, MD and Carla S. Wilson, MD, PhD

358 Follicular Lymphoma

Aaron Auerbach, MD, MPH and C. Cameron Yin, MD, PhD

364 Mantle Cell Lymphoma

Aaron Auerbach, MD, MPH

370 Diffuse Large B-Cell Lymphoma

Nadine Aguilera, MD

380 Burkitt Lymphoma

Aaron Auerbach, MD, MPH and Carlos Bueso-Ramos, MD, PhD

MATURE T- AND NK-CELL NEOPLASMS

388 T-Cell Prolymphocytic Leukemia

Nadine Aguilera, MD

392 NK-Cell Large Granular Lymphocytic Leukemia

Nadine Aguilera, MD

396 Aggressive NK-Cell Leukemia

Nadine Aguilera, MD

400 Extranodal NK-/T-Cell Lymphoma, Nasal Type

Aaron Auerbach, MD, MPH and L. Jeffrey Medeiros, MD

404 Adult T-Cell Leukemia/Lymphoma

Nadine Aguilera, MD

410 Intestinal T-Cell Lymphoma

Aaron Auerbach, MD, MPH and Sa A. Wang, MD

416 Hepatosplenic T-Cell Lymphoma

Aaron Auerbach, MD, MPH and Roberto N. Miranda, MD

420 Subcutaneous Panniculitis-Like T-Cell Lymphoma

Aaron Auerbach, MD, MPH

424 Mycosis Fungoides/Sézary Syndrome

Aaron Auerbach, MD, MPH and Sa A. Wang, MD

428 Primary Cutaneous CD30-Positive T-Cell

Lymphoproliferative Disorders

Aaron Auerbach, MD, MPH

432 Peripheral T-Cell Lymphoma, NOS

Aaron Auerbach, MD, MPH

438 Angioimmunoblastic T-Cell Lymphoma

Aaron Auerbach, MD, MPH

444 Anaplastic Large Cell Lymphoma, ALK Negative

Mohammad A. Vasef, MD

450 Anaplastic Large Cell Lymphoma, ALK Positive

Mohammad A. Vasef, MD

SECTION 7: MOLECULAR PATHOLOGY OF DENDRITIC CELL AND HISTIOCYTIC NEOPLASMS

458 Histiocytic Sarcoma

Nadine Aguilera, MD

466 Tumors Derived From Langerhans Cells

Guanghua Wang, MD

472 Interdigitating Dendritic Cell Tumor

Aaron Auerbach, MD, MPH and Sa A. Wang, MD

476 Follicular Dendritic Cell Neoplasm

Aaron Auerbach, MD, MPH

SECTION 8: MOLECULAR PATHOLOGY OF SOLID TUMORS HEAD AND NECK, INCLUDING SINONASAL TUMORS AND SALIVARY GLANDS

482 HPV-Associated Head and Neck Carcinomas

Thèrése Bocklage, MD

488 Head and Neck Mucosal Squamous Cell Carcinoma, Non-HPV Related

Thèrése Bocklage, MD

494 Important Alterations in Non-HPV-Related Head and

Neck Squamous Cell Carcinoma

Thèrése Bocklage, MD

496 Translocation-Specific Salivary Gland Tumors 1

Thèrése Bocklage, MD

504 Translocation-Specific Salivary Gland Tumors 2

Thèrése Bocklage, MD

512 Nasopharyngeal EBV-Related Squamous Cell Carcinoma

Thèrése Bocklage, MD

516 Other Head and Neck Tumors

Thèrése Bocklage, MD

THYROID

524 Papillary Thyroid Carcinoma

Giovanni Insuasti-Beltran, MD

528 Follicular Thyroid Carcinoma

Giovanni Insuasti-Beltran, MD

532 Poorly Differentiated Thyroid Carcinoma

Von Samedi, MD, PhD

536 Undifferentiated Thyroid Carcinoma

Von Samedi, MD, PhD

540 Medullary Thyroid Carcinoma

Giovanni Insuasti-Beltran, MD

LUNG546 Adenocarcinoma, Lung

Jeremy C. Wallentine, MD

554 Squamous Cell Carcinoma, Lung

Jeremy C. Wallentine, MD

558 Small Cell Neuroendocrine Carcinoma

Samuel Reynolds, MD

562 Mesothelioma

Mohammad A. Vasef, MD

LUMINAL GASTROINTESTINAL TRACT

564 Gastric Adenocarcinoma

Joshua Anspach Hanson, MD

568 Colorectal Adenocarcinoma and Precancerous Lesions

Joshua Anspach Hanson, MD

574 Gastrointestinal Stromal Tumor

Joshua Anspach Hanson, MD

LIVER582 HNF1a-Inactivated Hepatocellular Adenoma

Joshua Anspach Hanson, MD

586 ß-Catenin-Activated Hepatocellular Adenoma

Joshua Anspach Hanson, MD

590 Inflammatory Hepatocellular Adenoma

Joshua Anspach Hanson, MD

594 Hepatocellular Carcinoma

Rama Gullapalli, MD, PhD

PANCREATICOBILIARY

598 Pancreatic Ductal Adenocarcinoma

Von Samedi, MD, PhD

602 Pancreatic Mucinous Cystic Neoplasm

Von Samedi, MD, PhD

604 Pancreatic Intraductal Papillary Mucinous Neoplasm

Von Samedi, MD, PhD

606 Cholangiocarcinoma

Rama Gullapalli, MD, PhD

TESTIS

608 Testicular Germ Cell Tumors

Edgar Fischer, MD, PhD

KIDNEY

614 Clear Cell Renal Cell Carcinoma

Edgar Fischer, MD, PhD

618 Chromophobe Renal Cell Carcinoma

Edgar Fischer, MD, PhD

620 Papillary Renal Cell Carcinoma

Edgar Fischer, MD, PhD

622 TFE3-Rearranged and TFEB-Altered Renal Cell Carcinomas

Edgar Fischer, MD, PhD

626 Wilms Tumor

Marc Barry, MD

632 Clear Cell Sarcoma of Kidney

Marc Barry, MD

634 Oncocytoma

Marc Barry, MD

636 Rhabdoid Tumor of Kidney

Marc Barry, MD

BLADDER638 Urothelial Carcinoma

Marc Barry, MD

ADRENAL644 Pheochromocytoma/Paraganglioma

Samuel Reynolds, MD

650 Adrenal Cortical Carcinoma

Samuel Reynolds, MD

656 Neuroblastoma

Samuel Reynolds, MD, Thèrése Bocklage, MD, and Giovanni Insuasti-Beltran, MD

664 Adrenal Cortical Adenoma

Samuel Reynolds, MD

PROSTATE

668 Prostatic Adenocarcinoma, Acinar Type and High-Grade Prostatic Intraepithelial Neoplasia

Edgar Fischer, MD, PhD

BREAST

672 ADH and DCIS (Dysplastic, Premalignant)

David G. Hicks, MD

678 Ductal Carcinomas

David G. Hicks, MD

684 Lobular Carcinoma

David G. Hicks, MD

690 Carcinoma With Medullary Features, Breast

Rania Bakkar, MD

696 Metaplastic Breast Carcinoma

Rania Bakkar, MD

702 Phyllodes Tumors

Rania Bakkar, MD

708 Basal-Like and Triple-Negative Carcinomas

David G. Hicks, MD and Susan C. Lester, MD, PhD

CERVIX/VULVA/VAGINA

718 Preneoplastic Conditions, Cervix/Vulva/Vagina

Nancy Joste, MD

722 Squamous Cell Carcinoma, Cervix/Vulva/Vagina

Nancy Joste, MD

726 Adenocarcinoma, Cervix/Vulva/Vagina

Nancy Joste, MD

UTERUS730 Endometrial Intraepithelial Neoplasia

Lesley Lomo, MD

732 Uterine Endometrioid Carcinoma

Lesley Lomo, MD

736 Uterine Serous Carcinoma

Lesley Lomo, MD

738 Clear Cell Carcinoma, Uterus

Lesley Lomo, MD

742 Uterine Sarcomas

Thèrése Bocklage, MD

OVARIES/FALLOPIAN TUBE

750 Serous Tumors of Ovary and Fallopian Tube

Rania Bakkar, MD

756 Other Surface Epithelial Tumors of Ovary

Rania Bakkar, MD

762 Sex Cord-Stromal Tumors of Ovary

Rania Bakkar, MD

768 Germ Cell Tumor, Ovary

Aaron Auerbach, MD, MPH

SKIN

772 Preneoplastic Conditions, Skin

David Cassarino, MD, PhD

776 Melanoma

David Cassarino, MD, PhD

780 Squamous Cell Carcinoma, Skin

David Cassarino, MD, PhD

784 Basal Cell Carcinoma, Skin

David Cassarino, MD, PhD

788 Other Skin Conditions

David Cassarino, MD, PhD

BONE

792 Overview of Molecular Pathology of Bone and Soft Tissue Tumors

Thèrése Bocklage, MD

798 Osteosarcomas

Thèrése Bocklage, MD

806 Ewing Sarcoma

Thèrése Bocklage, MD

812 Other Small Round Blue Cell Sarcomas

Thèrése Bocklage, MD

818 Giant Cell Tumor of Bone

Thèrése Bocklage, MD

824 Intermediate and Malignant Cartilaginous Tumors of Bone

Thèrése Bocklage, MD

SOFT TISSUE834 Intermediate and Malignant Myofibroblastic/Fibroblastic Tumors

Thèrése Bocklage, MD

844 Liposarcomas

Thèrése Bocklage, MD

854 Muscle Sarcomas

Thèrése Bocklage, MD

864 Intermediate and Malignant Vascular Tumors

Thèrése Bocklage, MD

872 Malignant Peripheral Nerve Sheath Tumor

Thèrése Bocklage, MD and David R. Lucas, MD

878 Representative Genetic Findings in Bone and Soft Tissue Tumors

Thèrése Bocklage, MD

SARCOMAS OF UNCERTAIN DIFFERENTIATION

884 Rare Sarcomas of Uncertain Differentiation With Specific Molecular Alterations

Thèrése Bocklage, MD

CNS

894 Glioblastoma, IDH Wild Type

Mohammad A. Vasef, MD, Karen SantaCruz, MD, and Elisabeth Rushing, MD

898 Astrocytoma, IDH Mutant

Elisabeth Rushing, MD and Karen SantaCruz, MD

902 Pilocytic Astrocytoma

Aaron Auerbach, MD, MPH, Karen SantaCruz, MD, and Elisabeth Rushing, MD

906 Oligodendroglioma, IDH Mutant, and 1p/19q Codeleted

Aaron Auerbach, MD, MPH, Karen SantaCruz, MD, and Elisabeth Rushing, MD

910 Ependymoma

Fausto J. Rodríguez, MD

916 Medulloblastoma

Fausto J. Rodríguez, MD

922 Choroid Plexus Tumors

Fausto J. Rodríguez, MD

926 Meningioma

Karen SantaCruz, MD

930 Retinoblastoma

Fausto J. Rodríguez, MD

SECTION 9: QUALITY ASSURANCE AND REGULATORY ISSUES

936 Federal Agencies and Regulation of Laboratories

Amer Mahmoud, MD, FCAP

938 FDA Regulations

Yongjie Zhou, MD, PhD

944 Proficiency Testing and Accreditation

Amer Mahmoud, MD, FCAP

기타  의학도서에 관련된 문의사항은 고객센터(02-854-2738) 또는 저희 성보의학서적 홈페이지내 도서문의 게시판에 문의바랍니다.
감사합니다.
성보의학서적 "http://www.medcore.kr

상품결제정보

배송정보

• 배송 방법 : 택배
• 배송 지역 : 전국지역
• 배송 비용 : 2,500원
• 배송 기간 : 3일 ~ 5일
• 배송 안내 :

  
  

고객님께서 저희 성보의학서적에서 주문을 하신 주문번호가 생성이 되면 그에 따른 발송준비 및 배송절차는 다음과 같습니다

- 일반적으로 배송기간은 입금확인일로부터 3일 이내 배송을 원칙으로 합니다. 이는 재고가 확보된 도서의 경우입니다.
(단, 산간이나 지방 및 도서지역의 경우 약 1~2일이 더 소요될 수 있습니다.)
- 배송의 시점은 고객님의 주문 이후 입금확인 과정을 거쳐 배송이 됩니다.
- 주문도서의 배송 시 휴일이 포함된 경우는 24시간 순연됩니다.
- 배송료는 회원주문, 비회원주문 모두 2,500원 입니다. (일부 도서 및 산간지역은 추가 배송비 발생)
- 주문 금액이 30,000원 이상일 경우에는 무료로 배송해 드립니다.
- 반품/취소.환불 시 배송비는 무료로 배송이 되었을 경우, 처음 발생한 배송비까지 소급 적용될 수 있으며,
상품 하자로 인한 도서 교환시에는 무료로 가능합니다.
- 성보의학서적의 기본배송방법으로 택배서비스(한진택배&우체국)를 이용합니다.





해외원서의 경우
- 국내에서 재고를 보유한 업체가 없는 경우 해외주문을 해야 하는 상황이 생깁니다.
이 경우 4~5주 안에 공급이 가능하며 현지 출판사 사정에 따라 구입이 어려운 경우 2~3주 안에 공지해 드립니다.
- 재고 유무는 주문 전 사이트 상에서 배송 안내 문구로 구분 가능하며, 필요에 따라 전화 문의 주시면 거래처를 통해
다시 한번 국내재고를 확인해 드립니다.

- 해외 주문 도서는 고객님의 요청에 의해 주문하는 '개인주문' 상품으로, 단순한 고객변심/착오로 인한 취소, 교환, 반품은 불가능합니다.
- 해외주문 시 도서가격 및 수입 제반 비용 등을 모두 선결제로 진행하고 재고 관련 등의 사유로 취소, 교환, 반품이 불가능하오니
이점 꼭 숙지하시고 해외주문시 신중하게 주문하여 주시기 바랍니다.

교환 및 반품정보

반품안내
전자상거래에 의한 소비자보호에 관한 법률에 의거 반품 가능 기간내에는 반품을 요청하실 수 있습니다.

반품가능기간
- 단순변심 : 물품 수령 후 14일 이내 (단, 고객님의 요청으로 주문된 해외원서 제외)

- 주문하신 것과 다른 상품을 받으신 경우

- 파본인 상품을 받으신 경우
- 배송과정에서 손상된 상품을 받으신 경우

- 개봉된 DVD, CD-ROM, 카세트테이프 (단, 배송 중 파손된 상품 제외)

- 탐독의 흔적이 있는 경우
- 소비자의 실수로 상품이 훼손된 경우
- 고객님의 주문으로 수입된 해외 도서인 경우
- 수령일로 14일 지난 상품의 경우

- 해외 주문 도서는 고객님의 요청에 의해 주문하는 '개인주문' 상품으로, 단순한 고객변심/착오로 인한 취소, 교환, 반품은 불가능합니다.
- 해외주문 시 도서가격 및 수입 제반 비용 등을 모두 선결제로 진행하고 재고 관련 등의 사유로 취소, 교환, 반품이 불가능하오니
  이점 꼭 숙지하시고 해외주문시 신중하게 주문하여 주시기 바랍니다.

반품절차
- 배송완료후 3일 이내에 고객센터 02-854-2738 혹은 1:1 문의게시판을 통해 교환 및 반품 의사를 알려주세요.
- 도서는 택배 또는 등기우편으로 보내주시기 바랍니다.
- 14일 이내에 교환/반품/환불 받으실 상품이 회수되어야 하며, 반품과 환불의 경우 상품주문시 면제받으셨던
  배송비와 반품배송비까지 고객님께서 부담하시게 됩니다.

반품주소
(10881) 서울시 구로구 구로중앙로26길 32(구로동) 1층(성보의학서적)
전화) 02-854-2738

환불방법
- 대금은 반품 확인 후에, 카드취소/ 적립금 지급/ 계좌로 환불조치 해 드립니다.
- 카드결제 시 카드 승인취소절차를 밟게 되며 무통장입금시 현금 환불 혹은 적립금으로 변환 가능합니다.
- 반품도서와 함께 도서명, 주문번호와 환불계좌번호를 알려주시면 빠른 처리 가능합니다.

서비스문의

고객센터: (02)854-2738